Katherine Lemaster
Family · Beaumont, TXNPI 1265474423
Payments from drug & device makers
Across 55 payments — averaging $22.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$152
- Johnson & Johnson$126
- Pfizer$106
- Pharmaessentia USA Corporation$82
- Tempus AI, Inc$74
- Merck$69
- plus $651 from 21 others
What the payments were for
- Food & beverage$1,15792%
- Education$1028%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 6 | $152 |
| Johnson & Johnson | 3 | $126 |
| Pfizer | 6 | $106 |
| Pharmaessentia USA Corporation | 4 | $82 |
| Tempus AI, Inc | 3 | $74 |
| Merck | 3 | $69 |
| Eisai Inc. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Sanofi | 2 | $52 |
| Lilly USA, LLC | 2 | $50 |
| Sobi, Inc | 1 | $46 |
| Incyte Corporation | 2 | $44 |
| EMD Serono, Inc. | 2 | $42 |
| Deciphera Pharmaceuticals Inc. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $35 |
| AstraZeneca | 1 | $29 |
| Bayer | 1 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| GSK | 1 | $18 |
| Array Biopharma Inc | 1 | $17 |
| Springworks Therapeutics, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Exelixis Inc. | 1 | $16 |
| Rigel Pharmaceuticals, Inc. | 1 | $13 |
| Acrotech Biopharma Inc. | 1 | $12 |
How this compares
$1,259 in reported general payments places this provider in the 70th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 172 | $1,523 |
| Nystatin | 41 | $657 |
| Dexamethasone | 21 | $582 |
| ValacyclovirValacyclovir Hcl | 14 | $450 |
| Ondansetron OdtOndansetron | 20 | $257 |
| CefuroximeCefuroxime Axetil | 20 | $247 |
| Gabapentin | 23 | $242 |
| Prochlorperazine Maleate | 18 | $208 |
| Warfarin Sodium | 15 | $191 |
| Prednisone | 25 | $187 |
| Alprazolam | 17 | $166 |
| Ciprofloxacin Hcl | 15 | $155 |
| Potassium Chloride | 22 | $140 |
| Pantoprazole Sodium | 17 | $100 |
| Doxycycline Hyclate | 14 | $89 |
Paid to pharmacies, not to this prescriber.
Other family in Beaumont
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.